CONCERT PROMOTION/TICKET SALES DISPUTE
COPYRIGHT INFRINGEMENT/INDEPENDENT CREATION
October 28, 2010Stan Soocher
Former Rutgers University star quarterback Ryan Hart got another shot at suing video game company Electronic Arts Inc., which allegedly earned billions by exploiting his persona and that of other college football stars. A federal judge in the District of New Jersey recently dismissed Hart's case but gave him 20 days to file an amended complaint to beef up one of his claims: that Electronic Art, based in Redwood City, CA, infringed on his right of publicity.
October 28, 2010Mary Pat GallagherThe U.S. District Court for the Eastern District of New York dismissed a federal RICO claim that alleged the defendants took the basis for their TV program The Great American Road Trip from a TV show idea created by the plaintiffs.
October 28, 2010Stan SoocherAll the latest you need to know.
October 28, 2010ALM Staff | Law Journal Newsletters |Highlights of the latest intellectual property news from around the country.
October 28, 2010Howard J. Shire and Matthew BerkowitzWho's doing what; who's going where.
October 28, 2010ALM Staff | Law Journal Newsletters |Recent news events for your review.
October 28, 2010ALM Staff | Law Journal Newsletters |The Seventh Circuit's recent decision in Specialized Seating v. Greenwich Industries, L.P., highlights several important considerations that are often overlooked by counsel representing clients who claim trade dress rights in product designs. Paramount among those considerations is the effect that claims in a utility patent can have on the availability of trade dress protection.
October 28, 2010James W. FarisThe increased level of enforcement activity by the FDA has focused the attention of consumers and the plaintiffs' bar on the increased frequency with which physicians prescribe FDA-approved drugs and medical devices for unapproved uses. Plaintiffs' attorneys increasingly choose to name prescribing physicians in their products liability suits as co-defendants, pleading both medical malpractice and other associated tort claims against these physicians, and often premising such claims upon the decision to prescribe for a so-called "off-label" or unapproved use. Thus, the continuing expansion of off-label uses of drugs and devices has led to numerous potential legal minefields for the prescribing physicians.
October 28, 2010Lori G. Cohen and Sara K. Thompson